Emerging prognostic biomarkers in advanced cutaneous melanoma: a literature update

  • Published on 02/12/2024
  •  Reading time: 4 min.

Gabriele Roccuzzo a,* , Eleonora Bongiovanni a,* , Luca Tonella a , Valentina Pala a , Sara Marchisio b , Alessia Ricci b , Rebecca Senetta b , Luca Bertero b , Simone Ribero a,* , Enrico Berrino c,d , Caterina Marchiò c,d , Anna Sapino c,d , Pietro Quaglino a,§ & Paola Cassoni b,§

a Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy
b Pathology Unit, Department of Medical Sciences, University of Turin, Turin, Italy
c Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy
d Department of Medical Sciences, University of Turin, Turin, Italy

CONTACT Simone Ribero mailto:simone.ribero@unito.it Department of Medical Sciences, Section of Dermatology, University of Turin, Via Cherasco 23, Turin 10126, Italy

Abstract

Introduction Over the past two years, the scientific community has witnessed an exponential growth in research focused on identifying prognostic biomarkers for melanoma, both in pre-clinical and clinical settings. This surge in studies reflects the need of developing effective prognostic indicators in the field of melanoma.
Areas covered The aim of this work is to review the scientific literature on the most recent findings on the development or validation...

ContentGeneMD

To continue reading this article in Full-Text...

* Access is totally free, without commitment or condition. Service exclusively reserved for healthcare professionals.

Peer-Reviewed Journals A-Z

Search | Advanced search

Get the latest news in Dermatology

Receive our newsletter to stay up to date with the latest news in Dermatology